Sterling Capital Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.8K Sell
110
-859
-89% -$127K ﹤0.01% 1867
2026
Q1
$90.2K Sell
969
-702
-42% -$62.2K ﹤0.01% 1424
2025
Q4
$134K Sell
1,671
-399
-19% -$33.4K ﹤0.01% 1428
2025
Q3
$202K Buy
2,070
+1,259
+155% +$101K ﹤0.01% 1314
2025
Q2
$56.5K Buy
811
+776
+2,217% +$44.3K ﹤0.01% 1475
2025
Q1
$1.74K Buy
35
+2
+6% +$126 ﹤0.01% 2642
2024
Q4
$2.31K Hold
33
﹤0.01% 2751
2024
Q3
$3.46K Buy
+33
New +$3.86K ﹤0.01% 1919

Other funds holding ACLS

Sterling Capital Management's ACLS Position: Q2 2026 in Review

Sterling Capital Management reduced its Axcelis (ACLS) stake by 89% in Q2 2026, selling an estimated $127K and leaving 110 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1867.

Sterling Capital Management first reported a position in ACLS in Q3 2024 and has held it in 8 quarters since. The position peaked at $202K in Q3 2025. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Sterling Capital Management held 110 shares of Axcelis worth $20.8K as of Q2 2026.
  • Sterling Capital Management sold 859 Axcelis shares in Q2 2026, an estimated $127K.
  • Axcelis made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1867 holding.
  • Sterling Capital Management first reported a position in Axcelis in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Axcelis position peaked at $202K in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.